APP and Alzheimer disease: The reported reduction in BECN1 in AD brains [41], [42] and the increased plaque formation and neurodegeneration in Becn1+/−APP mice [41] led us to investigate whether Becn1 deficiency affected APP production, processing, or degradation in vitro.